Immunomedics, Inc.

300 American Road
Morris Plains,  NJ  07950

United States
http://www.immunomedics.com/
  • Booth: 2079

Immunomedics is a leader in next generation antibody-drug conjugate (ADC) technology, committed to helping transform the lives of people with hard-to-treat cancers. Our proprietary ADC binds to Trop-2-expressing cancer cells and is internalized with the subsequent release of SN-38 via hydrolysis of the linker. SN-38 interacts with topoisomerase I and prevents re-ligation of topoisomerase I-induced single strand breaks. For additional information, please visit our website, Immunomedics.com.


  •  
  •      
     

  •  
  •